Cargando…
Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas
BACKGROUND: Angiogenesis is the target of several agents in the treatment of malignancies, including renal cell carcinoma (RCC). There is a real need for surrogate biomarkers that can predict selection of patients who may benefit from antiangiogenic therapies, prediction of disease outcome and which...
Autores principales: | Paule, Bernard, Bastien, Laurence, Deslandes, Emmanuelle, Cussenot, Olivier, Podgorniak, Marie-Pierre, Allory, Yves, Naïmi, Benyoussef, Porcher, Raphael, de La Taille, Alexandre, Menashi, Suzanne, Calvo, Fabien, Mourah, Samia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873294/ https://www.ncbi.nlm.nih.gov/pubmed/20502715 http://dx.doi.org/10.1371/journal.pone.0010715 |
Ejemplares similares
-
EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
por: Bougatef, Faten, et al.
Publicado: (2010) -
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
por: Lescaille, Géraldine, et al.
Publicado: (2012) -
A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling
por: Lebbe, Celeste, et al.
Publicado: (2012) -
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
por: Khayati, Farah, et al.
Publicado: (2015) -
A novel tumor suppressor function of Kindlin-3 in solid cancer
por: Djaafri, Ibtissem, et al.
Publicado: (2014)